EPO and preeclampsia: The administration of Epo 50 IU/kg, pHBSP for 10 days at the dosages of 10 μg/kg and 250 μg/kg in pregnant animals with ADMA-like preeclampsia led to a decrease in CED by 16.1%, 17.7%, and 48.6% (p = 0.0006), indicating improved endothelial function.